Blasecki J W, Tevethia S S
Int J Cancer. 1975 Aug 15;16(2):275-83. doi: 10.1002/ijc.2910160210.
Specific cell-mediated immunity to SV40 tumor-specific transplantation antigen (TSTA) in BALB/c mice undergoing progressive tumorigenesis by syngeneic SV40-transformed cells (VLM) was investigated in vivo using a tumor-cell neutralization test. Specific cellular reactivity to SV40 TSTA was not detected in BALB/c mice bearing large tumors (10-15 mm mean diameter) but was demonstrable after tumor excision. Specific cytotoxic reactivity against syngeneic SV40-transformed cells in vivo could be restored to lymphoid cells from VLM tumor-bearing mice either by culturing the lymphoid cells in vitro or by treating them with papain or trypsin. Enzyme-treated lymphoid cells from MCA tumor-bearing BALB/c mice had no cytotoxic reactivity against VLM cells. These studies suggest that tumor-bearing hosts possess lymphocytes which are sensitized to the TSTA of the tumor but that the reactivity of these lymphocytes is blocked.
利用肿瘤细胞中和试验在体内研究了通过同基因SV40转化细胞(VLM)进行渐进性肿瘤发生的BALB/c小鼠对SV40肿瘤特异性移植抗原(TSTA)的特异性细胞介导免疫。在患有大肿瘤(平均直径10 - 15毫米)的BALB/c小鼠中未检测到对SV40 TSTA的特异性细胞反应性,但在肿瘤切除后可得到证实。通过体外培养淋巴细胞或用木瓜蛋白酶或胰蛋白酶处理,体内对同基因SV40转化细胞的特异性细胞毒性反应性可恢复到来自VLM荷瘤小鼠的淋巴细胞。来自MCA荷瘤BALB/c小鼠的经酶处理的淋巴细胞对VLM细胞没有细胞毒性反应性。这些研究表明,荷瘤宿主拥有对肿瘤TSTA敏感的淋巴细胞,但这些淋巴细胞的反应性被阻断。